Cargando…

Treatment of rats with Jiangzhi Capsule improves liquid fructose-induced fatty liver: modulation of hepatic expression of SREBP-1c and DGAT-2

BACKGROUND: Jiangzhi Capsule is an Australian listed patented traditional Chinese medicine and has been used for management of lipid abnormalities over the past 10 years. To obtain a better understanding regarding Jiangzhi Capsule, the present study investigated the effects and underlying mechanisms...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Yuanyang, Pan, Yongquan, Yang, Yifan, Batey, Robert, Wang, Jianwei, Li, Yuhao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467629/ https://www.ncbi.nlm.nih.gov/pubmed/26031670 http://dx.doi.org/10.1186/s12967-015-0529-6

Ejemplares similares

Structural and Functional Modulation of Gut Microbiota by Jiangzhi Granules during the Amelioration of Nonalcoholic Fatty Liver Disease
por: Wang, Rui-rui, et al.
Publicado: (2021)

Identify Molecular Mechanisms of Jiangzhi Decoction on Nonalcoholic Fatty Liver Disease by Network Pharmacology Analysis and Experimental Validation
por: Wang, Lei, et al.
Publicado: (2020)

Oleanolic Acid Diminishes Liquid Fructose-Induced Fatty Liver in Rats: Role of Modulation of Hepatic Sterol Regulatory Element-Binding Protein-1c-Mediated Expression of Genes Responsible for De Novo Fatty Acid Synthesis
por: Liu, Changjin, et al.
Publicado: (2013)

Treatment with Ginger Ameliorates Fructose-Induced Fatty Liver and Hypertriglyceridemia in Rats: Modulation of the Hepatic Carbohydrate Response Element-Binding Protein-Mediated Pathway
por: Gao, Huanqing, et al.
Publicado: (2012)

Jiangzhi Ligan Decoction Inhibits GSDMD-Mediated Canonical/Noncanonical Pyroptosis Pathways and Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease
por: Yin, Kangkang, et al.
Publicado: (2021)

Quantitative determination of multi-class bioactive constituents for quality control of Yiqi Jiangzhi Granules
por: Guo, Shaobo, et al.
Publicado: (2022)

Improvement of Liquid Fructose-Induced Adipose Tissue Insulin Resistance by Ginger Treatment in Rats Is Associated with Suppression of Adipose Macrophage-Related Proinflammatory Cytokines
por: Wang, Jianwei, et al.
Publicado: (2013)

Hepatic deletion of Mboat7 (LPIAT1) causes activation of SREBP-1c and fatty liver
por: Xia, Mingfeng, et al.
Publicado: (2021)

Hepatic VLDL secretion: DGAT1 determines particle size but not particle number, which can be supported entirely by DGAT2
por: Irshad, Zehra, et al.
Publicado: (2019)

Baicalein Prevents Fructose-Induced Hepatic Steatosis in Rats: In the Regulation of Fatty Acid De Novo Synthesis, Fatty Acid Elongation and Fatty Acid Oxidation
por: Li, Pan, et al.
Publicado: (2022)

Pharmacokinetic Comparisons of Different Combinations of Yigan Jiangzhi Formula in Rats: Simultaneous Determination of Fourteen Components by UPLC-MS/MS
por: Wang, Yang, et al.
Publicado: (2020)

Liraglutide reduces fatty degeneration in hepatic cells via the AMPK/SREBP1 pathway
por: WANG, YAN-GUI, et al.
Publicado: (2015)

The triglyceride synthesis enzymes DGAT1 and DGAT2 have distinct and overlapping functions in adipocytes
por: Chitraju, Chandramohan, et al.
Publicado: (2019)

Hepatic Oxidative Stress in Fructose-Induced Fatty Liver Is Not Caused by Sulfur Amino Acid Insufficiency
por: Kunde, Sachin S., et al.
Publicado: (2011)

Lipocalin-2 in Fructose-Induced Fatty Liver Disease
por: Lambertz, Jessica, et al.
Publicado: (2017)

Overexpression of DGAT2 Regulates the Differentiation of Bovine Preadipocytes
por: Guo, Pan-Pan, et al.
Publicado: (2023)

The olive DGAT2 gene is developmentally regulated and shares overlapping but distinct expression patterns with DGAT1
por: Banilas, Georgios, et al.
Publicado: (2011)

SREBP activation contributes to fatty acid accumulations in necroptosis
por: Lu, Daniel, et al.
Publicado: (2023)

Fructose Induced Endotoxemia in Pediatric Nonalcoholic Fatty Liver Disease
por: Jin, Ran, et al.
Publicado: (2014)

Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease
por: ter Horst, Kasper W., et al.
Publicado: (2017)

Fatty Liver Promotes Fibrosis In Monkeys Consuming High Fructose
por: Cydylo, Michael A., et al.
Publicado: (2017)

The Contribution of Dietary Fructose to Non-alcoholic Fatty Liver Disease
por: Yu, Siyu, et al.
Publicado: (2021)

SREBP1c mediates the effect of acetaldehyde on Cidea expression in Alcoholic fatty liver Mice
por: He, Qi, et al.
Publicado: (2018)

Industrial Trans Fatty Acids Stimulate SREBP2‐Mediated Cholesterogenesis and Promote Non‐Alcoholic Fatty Liver Disease
por: Oteng, Antwi‐Boasiako, et al.
Publicado: (2019)

Paradoxical Coupling of Triglyceride Synthesis and Fatty Acid Oxidation in Skeletal Muscle Overexpressing DGAT1
por: Liu, Li, et al.
Publicado: (2009)

Mechanistic insights into the effects of SREBP1c on hepatic stellate cell and liver fibrosis
por: Su, Shengyan, et al.
Publicado: (2020)

Fructose and the Liver
por: Muriel, Pablo, et al.
Publicado: (2021)

Effect of BuShen JiangZhi Recipe on Atherosclerosis in ApoE(−/-) Mice by Regulating the Expression of Anpep via mmu_circRNA_22187
por: Yan, Li, et al.
Publicado: (2021)

Organismal Fructose Metabolism in Health and Non-Alcoholic Fatty Liver Disease
por: Skenderian, Shea, et al.
Publicado: (2020)

Relevance of fructose intake in adolescence for fatty liver indices in young adulthood
por: Perrar, Ines, et al.
Publicado: (2021)

Liver-Specific Expression of Transcriptionally Active SREBP-1c Is Associated with Fatty Liver and Increased Visceral Fat Mass
por: Knebel, Birgit, et al.
Publicado: (2012)

An RNAi therapeutic targeting hepatic DGAT2 in a genetically obese mouse model of nonalcoholic steatohepatitis
por: Yenilmez, Batuhan, et al.
Publicado: (2022)

Impact of silencing hepatic SREBP-1 on insulin signaling
por: Jideonwo, Victoria, et al.
Publicado: (2018)

The SCAP/SREBP Pathway: A Mediator of Hepatic Steatosis
por: Moon, Young-Ah
Publicado: (2017)

Antrodan Alleviates High-Fat and High-Fructose Diet-Induced Fatty Liver Disease in C57BL/6 Mice Model via AMPK/Sirt1/SREBP-1c/PPARγ Pathway
por: Chyau, Charng-Cherng, et al.
Publicado: (2020)

Chronic Oleoylethanolamide Treatment Decreases Hepatic Triacylglycerol Level in Rat Liver by a PPARγ/SREBP-Mediated Suppression of Fatty Acid and Triacylglycerol Synthesis
por: Romano, Adele, et al.
Publicado: (2021)

Efficient Hepatitis C Virus Particle Formation Requires Diacylglycerol Acyltransferase 1 (DGAT1)
por: Herker, Eva, et al.
Publicado: (2010)

Estrogen stimulates SREBP2 expression in hepatic cell lines via an estrogen response element in the SREBP2 promoter
por: Meng, Ye, et al.
Publicado: (2019)

Role of SREBPs in Liver Diseases: A Mini-review
por: Moslehi, Azam, et al.
Publicado: (2018)

SREBP-2 1784 G/C Genotype is Associated with Non-Alcoholic Fatty Liver Disease in North Indians
por: Bhatt, Surya Prakash, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_s83v7479ia6v8olh6bo2jfrmlg